| Name | Title | Contact Details |
|---|
Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.
Community For Youth is a Lesage, WV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Netwal Dental Laboratory Inc is a La Crosse, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Offering the benefits of resort-style amenities and an independent lifestyle, with access to award-winning lifecare services providing added peace of mind.
South Texas Blood & Tissue Center is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.